REG - Life Science REIT - Notice of AGM

Life Science ReitAnnouncement

Tue 15:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250429:nRSc6787Ga&default-theme=true

RNS Number : 6787G  Life Science REIT PLC  29 April 2025

29 April 2025

LEI 213800RG7JNX7K8F7525

Life Science REIT plc

("Life Science REIT" or the "Company")

Annual Report and Notice of Annual General Meeting ("AGM")

Following the announcement on 16 April 2025 of its full year results for the
year ended 31 December 2024 (RNS number: 1859F), the Company has today posted
the following documents to shareholders that have elected to receive hard
copies of shareholder communications:

·    2024 Annual Report;

·    Notice of 2025 Annual General Meeting (AGM); and

·    Letter of Availability.

In accordance with UK Listing Rules 6.4.1R and 6.4.3R and UK Disclosure
Guidance and Transparency Rules ("DTRs") 6.2.10R and 6.3.5R, the 2024 Annual
Report has been submitted to the Financial Conduct Authority's National
Storage Mechanism in both structured electronic format and in unedited full
text and the Notice of the 2025 AGM has been submitted to the NSM. A copy of
the 2024 Annual Report and the Notice of the 2025 AGM will shortly be
available for viewing at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

The AGM will be held at the offices of Ironstone Asset Management Limited, 3rd
Floor, 55 Wells Street, London, W1T 3PT at 10.00am on Tuesday 3 June 2025.

Enquiries:

 Ironstone Asset Management - Investment Adviser                      +44 20 3011 2160
 Simon Farnsworth, Managing Director

 Simon.farnsworth@ironstoneam.com

 Joanna Waddingham, Head of Investor Relations and Corporate Affairs

 Joanna.Waddingham@ironstoneam.com

 MUFG Corporate Governance Limited - Company Secretary

 labs_cosec@cm.mpms.mufg.com

 Panmure Liberum - Financial Adviser & Corporate Broker               +44 20 7886 2500

 Alex Collins / Tom Scrivens

 G10 Capital Limited - AIFM                                           +44 20 7397 5450

 Maria Baldwin

 FTI Consulting - Financial PR                                        +44 20 3727 1000

 Dido Laurimore / Richard Gotla / Oliver Parsons

 LifeScienceReit@fticonsulting.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOAILMITMTBTBBA